Quick answer: Weight regain after stopping a GLP-1 medicine like Ozempic, Wegovy or Mounjaro is common — studies show people often regain a large share of the lost weight within about a year of stopping. It happens because GLP-1 medicines treat the biology of appetite, not just behaviour; when the medicine stops, hunger signals return. The fix isn't willpower — it's a planned, doctor-led strategy for maintenance, tapering and habits.
Why do people regain weight after stopping GLP-1 medicines?
Obesity is a chronic, biological condition. GLP-1 medicines work by reducing appetite and slowing stomach emptying, which lowers how much you eat. When you stop, those appetite signals return to where your body wants them — and for most people that means increased hunger and a drift back toward the previous weight. This is the same pattern seen with stopping treatment for other chronic conditions; it isn't a personal failure.
In the STEP 1 trial extension, participants who stopped semaglutide regained about two-thirds of their lost weight within roughly a year — a clear sign that maintenance matters as much as the initial loss.
Does this mean GLP-1 medicines don't work?
No. It means they work the way treatment for a chronic condition works — the benefit continues while you're being treated and managed. The goal isn't necessarily to stop abruptly, but to plan the long game: a maintenance dose, a slow taper if appropriate, and lifestyle changes that hold. For background, see our Ozempic in India guide and the full GLP-1 weight loss guide.
How do you prevent weight regain?
A maintenance plan beats stopping cold
- Don't stop abruptly — discuss a maintenance dose or gradual taper with your doctor
- Build muscle — strength training protects the muscle that keeps metabolism up
- Prioritise protein — supports satiety and muscle retention
- Keep the habits — the routines you built on the medicine are what carry results forward
- Stay monitored — regular check-ins catch regain early, when it's easiest to act
Should you stay on a GLP-1 medicine long term?
For some people, long-term or maintenance dosing is the right clinical answer; for others, a structured taper with strong lifestyle support works. There's no single rule — it depends on your health profile, goals and how your body responds. This is a decision to make with a doctor, not alone. Compare the options in our semaglutide vs tirzepatide guide.
Ozempic, Wegovy and Mounjaro are Schedule H prescription medicines in India. Any decision to start, continue, taper or stop should be made with a qualified clinician.
The bottom line
Weight regain after stopping a GLP-1 isn't inevitable — but it's likely without a plan. The people who keep their results treat weight loss as ongoing care, not a one-off course. Start with a free eligibility check or book a free consultation to build a maintenance plan that lasts.
"The mistake isn't taking a GLP-1 — it's treating it like a sprint. Plan the maintenance phase from day one and regain stops being the default." — MetaFit Medical Team
Explore the topic
- GLP-1 weight loss in India
The complete guide to GLP-1 therapy, results and safety for Indian patients.
- Semaglutide in India
Wegovy, Ozempic and generic semaglutide — availability, cost and evidence.
- Check your GLP-1 eligibility
Find out whether doctor-supervised GLP-1 therapy is clinically appropriate for you.
References
- Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022 — roughly two-thirds of lost weight regained one year after stopping.
- Rubino D et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance. JAMA, 2021 (STEP 4) — continued treatment −7.9% vs +6.9% after switching to placebo.
- Fothergill E et al. Persistent metabolic adaptation 6 years after "The Biggest Loser" competition. Obesity, 2016 — resting metabolic rate stays suppressed after large weight loss.
This article is for general information and is not a substitute for individual medical advice. Prescription medicines referenced here are regulated in India by the Central Drugs Standard Control Organisation (CDSCO) and are dispensed only against a valid prescription from a registered medical practitioner.
Ready to Start Your Weight Loss Journey?
Get a personalized medical assessment from MetaFit's expert doctors — tailored for the Indian lifestyle.
Book a Free ConsultationOr download the app to get started
